60 Episodes

  1. Episode 39: The Euretina Retinal Medicine Clinical Research Award

    Published: 11/15/2023
  2. Episode 38: Preview of Euretina Congress 2023

    Published: 9/29/2023
  3. Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world

    Published: 9/15/2023
  4. Episode 36: The Ophthalmologica Lecture: Maximilian Pfau

    Published: 9/1/2023
  5. Episode 35: Treating PCV and Pachychoroid in Different Populations

    Published: 8/15/2023
  6. Episode 34: The Euretina Lecture: OncoVR

    Published: 7/31/2023
  7. Episode 33: The Euretina Innovation Summit - All You Need to Know

    Published: 7/3/2023
  8. Episode 32: Macular Holes and Glaucoma in Myopia

    Published: 6/15/2023
  9. Episode 31: Featured studies from the Ophthalmologica journal

    Published: 5/18/2023
  10. Episode 30: Intraocular Lymphoma: An Explainer

    Published: 5/2/2023
  11. Episode 29: How to get published in Euretina’s Journal, Ophthalmologica

    Published: 4/14/2023
  12. Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world

    Published: 3/30/2023
  13. Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?

    Published: 3/14/2023
  14. Episode 26: Tackling Acute Retinal Necrosis in Patients

    Published: 3/1/2023
  15. Episode 25: What individual patient data can tell us about treating macular holes

    Published: 2/15/2023
  16. Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?

    Published: 2/6/2023
  17. Episode 23: Everything You Need to Know About the New EBO-Euretina Exam

    Published: 1/17/2023
  18. Episode 22: Women in Retina

    Published: 12/1/2022
  19. Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma

    Published: 11/17/2022
  20. Episode 20: A Deep Dive into the MOLES System

    Published: 11/3/2022

2 / 3

Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.